Zyvox Injection, Solution
Product Images NDC 66298-5137

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zyvox (NDC 66298-5137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hp Halden Pharma As, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label2

Label for Zyvox 200 mg/100 mL (linezolid) intravenous injection. The label states it contains 10 IV bags of 100 mL each and is distributed by Pharmacia & Upjohn Division of Pfizer Inc., made in Singapore. Storage instructions specify to store at 25°C with excursions allowed, and a warning not to freeze. Barcodes, lot, and expiration placeholders are visible.*

FDA Label Image

Chemical Structure (Zyvox 01)

Chemical structure diagram of linezolid, the active ingredient in Zyvox injection. The diagram shows the molecular configuration used in its pharmaceutical formulation by Hp Halden Pharma AS.*

FDA Label Image

Figure 1 (Zyvox 02)

A line graph showing linezolid plasma concentration (µg/mL) over 12 hours after a 600 mg oral dose every 12 hours. The x-axis represents time after dose in hours, and the y-axis shows plasma concentration. Data points are indicated with error bars demonstrating variability at each time point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.